Site Search
Professionals 503 results
Capabilities 84 results
Practice Area
Our nationally recognized Appellate & Critical Motions (ACM) Practice delivers sophisticated legal advocacy and analysis before trial, at trial, and on appeal. From state trial courts to the U.S. Supreme Court, our ACM attorneys identify, preserve, and present the critical legal issues that can make the difference between winning and losing.
Practice Area
Trial skills matter—even in a world where few disputes ever see the inside of a courtroom. Winston has built a reputation as a trial lawyers’ firm, featuring seasoned litigators who leverage extensive courtroom experience to meet our clients’ business and legal objectives. Our long history of taking cases to trial—and winning—provides our clients with tremendous settlement leverage with their adversaries, as well as a substantial likelihood of a favorable resolution if, and when, they go to trial.
Practice Area
Our attorneys have extensive experience counseling U.S. and multinational public companies across a range of industries in all aspects of corporate governance, securities, and compliance matters. We advise public companies, boards of directors and their committees, and senior executives on the corporate governance and compliance matters that public companies and their leadership confront—from board structuring and succession planning to shareholder activism and SEC regulation. Drawing on our experience as seasoned counselors, we keep clients abreast of evolving trends and best practices to proactively manage any governance or compliance issues. We have assembled one of the most experienced teams of any law firm in the country that’s counseling public companies.
Experience 528 results
Experience
|April 29, 2026
KeHE Distributors, LLC - $500.0 Million Senior Secured Notes Offering
Winston & Strawn, LLC represented KeHE Distributors, LLC, a leading pure-play natural and organic, specialty and fresh food distribution company in North America in connection with a Rule 144A/Reg. S offering of $500 million aggregate principal amount of 7.125% senior secured notes due 2033 issued by KeHE Distributors, LLC, KeHE Finance Corp. and NextWave Distribution, Inc. Proceeds from the offering were used to partially repay amounts outstanding under the company's existing ABL facility and pay related fees and expenses.
Experience
|April 28, 2026
Winston & Strawn LLP Paris advised the management team of TRIGO, a global leader in quality management services for the transport sector, in connection with Montyon Capital’s acquisition of a majority stake and the management buy-in.
Experience
|April 27, 2026
Winston Represents Initial Purchasers in GABX Leasing’s $1 Billion Inaugural Senior Notes Offering
Winston & Strawn LLP represented the initial purchasers, BofA Securities, Inc., MUFG Securities Americas Inc., SMBC Nikko Securities America, Inc., and Wells Fargo Securities, LLC, in connection with GABX Leasing LLC’s inaugural $1 billion Rule 144A offering of senior notes, with GATX Corporation as guarantor. The offering consisted of $500 million of 4.625% Senior Notes due 2031 and $500 million of 5.300% Senior Notes due 2036. GABX Leasing LLC is a joint venture between GATX Corporation and Brookfield Infrastructure Partners L.P. and its institutional partners, formed in connection with the approximately $4.2 billion acquisition of a portfolio of approximately 101,000 railcars from Wells Fargo. This financing represents a key component of the joint venture’s capital structure and supports the continued expansion of one of the largest railcar leasing platforms in North America. This transaction underscores Winston’s market leading capital markets practice and its continued role advising global financial institutions on complex, large scale financings, particularly those supporting critical infrastructure and transportation assets.
Insights & News 7,124 results
Capital Markets & Securities Law Watch
|May 13, 2026
|4 Min Read
From 10-Q to 10-S: What the SEC’s Optional Semiannual Reporting Proposal Means for Public Companies
On May 5, 2026, the Securities and Exchange Commission (SEC) proposed optional semiannual Exchange Act reporting on a new Form 10-S, which represents a significant shift in the public company disclosure landscape.
Recognitions
|May 13, 2026
|1 Min Read
Pete Morgan Recognized With Rainmaker Award in ABF Journal’s 2026 Legends & Leaders Awards
Winston & Strawn partner Pete Morgan has been recognized as one of only 18 “Rainmakers” in ABF Journal’s 2026 Legends & Leaders Awards. The Rainmaker award recognizes the leading deal closers in the specialty finance industry—top performers delivering standout results.
In the Media
|May 12, 2026
|Less Than 1 Min Read
Jason Jun Shares Insights on Market Conditions in Leveraged Finance with Octus
Winston & Strawn partner and co-chair of the Leveraged Finance Practice, Jason Jun, was quoted in Octus’ Americas Leveraged Finance Weekly discussing evolving conditions in the leveraged finance market as deal activity begins to rebound following a slower close to April.
Other Results 77 results
Law Glossary
Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?
The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here.
Law Glossary
Maintained by the FDA, the Purple Book lists biologic products and biosimilar products that FDA has licensed under the Public Health Service Act. In addition, the Purple Book identifies the date each biologic obtained FDA licensure and indicates whether any biosimilar is interchangeable with its associated reference product.
Site Content
Blockchain is a technological system in which a digital list of records stored across a network. The network is a shared database comprised of a large number of computers. Blockchain is the primary technology for cryptocurrencies.